Chelikam Nikhila, Mohammad Zeeshan, Tavrawala Krishna, Krishnakumar Anjali N, Varghese Anitta, Shrivastav Tanvi Yogesh, Tarimci Baris, Kumar Sushil, Francis Stephan Z, Samala Venkata Vikramaditya, Patel Urvish K, Manjani Lokesh
Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Internal Medicine, BLK-Max Super Speciality Hospital, New Delhi, IND.
Cureus. 2022 Nov 23;14(11):e31826. doi: 10.7759/cureus.31826. eCollection 2022 Nov.
Introduction Globally, stroke is one of the top ten causes of death. The incidence of stroke in patients aged 44 years and younger was noted to have risen over the past three decades. This rise in stroke diagnosis among young adults could be attributed to multiple reasons, including the rising prevalence of comorbidities like diabetes, hypertension, substance use disorders (SUDs), etc. Aim & objectives This study's primary aim was to evaluate the prevalence of stroke in the US population and the prevalence of SUDs amongst patients with a prior history of stroke. The secondary aim was to evaluate the association between Stroke and SUDs. Methods Our population was obtained from the National Health and Nutrition Examination Survey (NHANES) between the years 2013 to 2018. We identified respondents diagnosed with stroke using the questionnaire and the history of various SUDs amongst this population. The data were analyzed using SAS software (Version 9.4). We performed univariate analysis using the chi-square and Mann-Whitney test, and a p-value of <0.05 was considered statistically significant. Results Two hundred sixty-four thousand seven hundred forty (264,740) respondents were included in this study, and 10435 (3.94%) respondents were noted to have a history of stroke. The population subset with a stroke diagnosis was older (68 years vs. 51 years). Higher prevalence was noted among the female sex (52.14% females vs. 47.86% males), Non-Hispanic white ethnicity, followed by Non-Hispanic black & then other Hispanics (47.56% vs.25.47% vs. 7.82%), and those belonging to a lower annual household income of $0-$25,000 and $25,000-$65,000 ( 46.61% vs. 35.93% ). (p<0.0001). After adjusting for socio-demographics and coexisting comorbidities, e-cigarette [OR: 2.03; 95% CI: 2.03-2.03], cocaine [OR: 1.54; 95%CI:1.54-1.54], heroin [OR: 1.83; 95%CI: 1.83-1.83], marijuana or hashish [OR: 1.01; 95% CI: 1.01-1.01], were observed to have an association with higher odds of stroke than the population without a history of using these illicit drugs. Conclusion Among respondents with a history of stroke, the use of cocaine was most prevalent, followed by marijuana/hashish, heroin, e-cigarettes, and injecting illegal drugs. The odds of having a stroke were two times higher in the population using an e-cigarette and higher among those using heroin, cocaine, and marijuana/ hashish. The Government should plan policy changes to treat SUDs in the USA, which could help reduce the stroke burden. Recall that bias and geographic variations in response rate by participants of the study were the limitations of our survey-based study.
引言
在全球范围内,中风是十大死因之一。据指出,在过去三十年中,44岁及以下患者的中风发病率有所上升。年轻成年人中风诊断率的上升可能归因于多种原因,包括糖尿病、高血压、物质使用障碍(SUDs)等合并症患病率的上升。
目的
本研究的主要目的是评估美国人群中中风的患病率以及有中风病史患者中物质使用障碍的患病率。次要目的是评估中风与物质使用障碍之间的关联。
方法
我们的研究人群来自2013年至2018年的国家健康与营养检查调查(NHANES)。我们通过问卷确定了被诊断为中风的受访者以及该人群中各种物质使用障碍的病史。使用SAS软件(版本9.4)对数据进行分析。我们使用卡方检验和曼-惠特尼检验进行单变量分析,p值<0.05被认为具有统计学意义。
结果
本研究纳入了264,740名受访者,其中10,435名(3.94%)受访者有中风病史。有中风诊断的人群子集年龄较大(68岁对51岁)。女性患病率较高(女性为52.14%,男性为47.86%),非西班牙裔白人种族,其次是非西班牙裔黑人,然后是其他西班牙裔(47.56%对25.47%对7.82%),以及家庭年收入较低的人群,即0美元至25,000美元和25,000美元至65,000美元(46.61%对35.93%)。(p<0.0001)。在调整了社会人口统计学和共存合并症后,发现电子烟[比值比(OR):2.03;95%置信区间(CI):2.03 - 2.03]、可卡因[OR:1.54;95%CI:1.54 - 1.54]、海洛因[OR:1.83;95%CI:1.83 - 1.83]、大麻或哈希什[OR:1.01;95%CI:1.01 - 1.01]与没有这些非法药物使用史的人群相比,中风几率更高。
结论
在有中风病史的受访者中,可卡因的使用最为普遍,其次是大麻/哈希什(大麻脂)、海洛因、电子烟和注射非法药物。使用电子烟的人群中风几率高出两倍,使用海洛因、可卡因和大麻/哈希什的人群中风几率更高。政府应规划政策变革以治疗美国的物质使用障碍,这可能有助于减轻中风负担。请注意,本基于调查的研究的局限性在于研究参与者的回忆偏差和地理区域的应答率差异。